PDSB
PDS Biotechnology Corporation
NASDAQ · Healthcare · Biotechnology · US
$0.22
+0.23%Leverage
- Debt / equity
- -1.22x
- Net debt / equity
- 0.34x
- Debt / assets
- 0.50x
- Debt / EBITDA
- -0.16x
- Net debt / EBITDA
- 0.05x
Liquidity & coverage
- Current ratio
- 0.57x
- Quick ratio
- 0.57x
- Cash ratio
- 0.45x
- Interest coverage
- -4.18x
- EBITDA / interest
- -4.08x
- Working capital
- -$5.3M
Cash & dividend
- FCF / debt
- -3.85x
- Cash flow / debt
- -3.85x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026